17:55
2026-06-05
letsdatascience.com
artificial-intelligence
Cambridge AI-designed vaccine shows safety in humans
A University of Cambridge team and spin-out DIOSynVax reported that a Phase 1 trial of an AI-designed "super-antigen" vaccine was safe and immunogenic in 39 healthy volunteers. The vaccine, whose acti…